Clinical Trial Update: Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated quetiapine as monotherapy for ambulatory bipolar spectrum disorder with moderate-to-severe hypomanic symptoms or mild manic symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Quetiapine (Seroquel) (quetiapine)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED